title: Prolonged treatment with transcutaneous electrical nerve stimulation (TENS) modulates neuro-gastric motility and plasma levels of vasoactive intestinal peptide (VIP), motilin and interleukin-6 (IL-6) in systemic sclerosis.
abstract: OBJECTIVE
  We assessed the effects of transcutaneous electrical nerve stimulation (TENS) on neurogastric functioning in scleroderma patients.
  
  
  METHODS
  Seventeen SSc patients underwent 30 min TENS treatment >10Hz at GI acupuncture points PC6 and ST36, once (acute TENS) and then after two weeks of TENS sessions for 30 min twice daily (prolonged TENS). Data collected at Visits 1 and 2 included gastric myoelectrical activity (GMA) by surface electrogastrography (EGG), heart rate variability (HRV) by surface electrocardiography (EKG), GI specific symptoms and health related SF-36 questionnaires. Plasma VIP, motilin and IL-6 levels were determined. Statistical analyses were performed by Student's t-test, Spearman Rank and p-values <0.05 were considered significant.
  
  
  RESULTS
  1. Only after prolonged TENS, the percentages of normal slow waves and average slow wave coupling (especially channels 1, 2 reflecting gastric pacemaker and corpus regions) were significantly increased; 2. the percentage of normal slow waves was significantly correlated to sympathovagal balance; 3. Mean plasma VIP and motilin levels were significantly decreased after acute TENS, (vs. baseline), generally maintained in the prolonged TENS intervals. Compared to baseline, mean plasma IL-6 levels were significantly increased after acute TENS, but significantly decreased after prolonged TENS. 4. After prolonged TENS, the frequency of awakening due to abdominal pain and abdominal bloating were significantly and modestly decreased, respectively.
  
  
  CONCLUSIONS
  In SSc patients, two weeks of daily TENS improved patient GMA scores, lowered plasma VIP, motilin and IL-6 levels and improved association between GMA and sympathovagal balance. This supports the therapeutic potential of prolonged TENS to enhance gastric myoelectrical functioning in SSc.
authors: Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA. tmcnearn@utmb.edu
authors: Terry A
authors: TA
authors: McNearney
authors: Hanaa S
authors: HS
authors: Sallam
authors: Sonya E
authors: SE
authors: Hunnicutt
authors: Dipti
authors: D
authors: Doshi
authors: Jiande D Z
authors: JD
authors: Chen
mesh_terms: D004562:Electrocardiography; D004576:Electromyography; D005260:Female; D005769:Gastrointestinal Motility / Q000502:physiology*; D018589:Gastroparesis / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D006304:Health Status; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008875:Middle Aged; D009037:Motilin / Q000097:blood; D017060:Patient Satisfaction; D012595:Scleroderma, Systemic / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D013270:Stomach / Q000294:innervation* / Q000502:physiology*; D004561:Transcutaneous Electric Nerve Stimulation / Q000379:methods*; D016896:Treatment Outcome; D014660:Vasoactive Intestinal Peptide / Q000097:blood
chemical_list: C508600:IL6 protein, human; D015850:Interleukin-6; D014660:Vasoactive Intestinal Peptide; D009037:Motilin